In an interview with Consultant360, Paul B. Rosenberg, MD, discussed his team’s research on using dronabinol, a legal form of synthetic THC, to treat agitation in patients with Alzheimer disease. What...
In a 2024 review, the International Psychogeriatric Association introduces a systematic method to manage agitation in patients with Alzheimer disease. Take our quiz to test your knowledge on this...
A new study found transcranial pulse stimulation treatment may improve behavioral symptoms such as aggression or agitation in patients with Alzheimer disease. Take our quiz to test your knowledge on its...
In a recent interview with Consultant360, Kasia Rothenberg, MD, PhD, a geriatric psychiatrist at the Cleveland Clinic Lou Ruvo Center for Brain Health, described the many obstacles to accurate testing. Do...
Individuals with Alzheimer disease may present with memory loss or other cognition concerns. Are you familiar with the non-memory symptoms that should determine if a patient needs further cognitive...
In their presentation at the Practical Updates in Primary Care 2023 Virtual Series, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C reviewed the pathophysiological mechanisms of agitation...
Increasing age is a risk factor for Alzheimer dementia (AD), and as the US population grows older and lives longer, new and existing cases of AD are projected to rise as well. How many older Americans are...
